BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han C, Wang SM, Lee SJ, Jun TY, Pae CU. Optimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical Practice. Chonnam Med J 2015;51:66-80. [PMID: 26306301 DOI: 10.4068/cmj.2015.51.2.66] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Jacobson M, Childers W, Abou‐gharbia M. Dopamine D 2 Partial Agonists – Discovery, Evolution, and Therapeutic Potential. In: Fischer J, Klein C, Childers WE, editors. Successful Drug Discovery. Wiley; 2019. pp. 83-130. [DOI: 10.1002/9783527814695.ch4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Fereidouni Z, Behnammoghadam M, Jahanfar A, Dehghan A. The Effect of Eye Movement Desensitization and Reprocessing (EMDR) on the severity of suicidal thoughts in patients with major depressive disorder: a randomized controlled trial. Neuropsychiatr Dis Treat 2019;15:2459-66. [PMID: 31695382 DOI: 10.2147/NDT.S210757] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
3 Tian JS, Liu SB, He XY, Xiang H, Chen JL, Gao Y, Zhou YZ, Qin XM. Metabolomics studies on corticosterone-induced PC12 cells: A strategy for evaluating an in vitro depression model and revealing the metabolic regulation mechanism. Neurotoxicol Teratol 2018;69:27-38. [PMID: 30076895 DOI: 10.1016/j.ntt.2018.07.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
4 Yoon S, Jeon SW, Ko Y, Patkar AA, Masand PS, Pae C, Han C. Adjunctive Brexpiprazole as a Novel Effective Strategy for Treating Major Depressive Disorder: A Systematic Review and Meta-Analysis. J Clin Psychopharmacol 2017;37:46-53. [DOI: 10.1097/jcp.0000000000000622] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.6] [Reference Citation Analysis]
5 Wang L, Zhang Y, Du X, Ding T, Gong W, Liu F. Review of antidepressants in clinic and active ingredients of traditional Chinese medicine targeting 5-HT1A receptors. Biomedicine & Pharmacotherapy 2019;120:109408. [DOI: 10.1016/j.biopha.2019.109408] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 Pan PY, Fu AT, Yeh CB. Aripiprazole/Methylphenidate Combination in Children and Adolescents with Disruptive Mood Dysregulation Disorder and Attention-Deficit/Hyperactivity Disorder: An Open-Label Study. J Child Adolesc Psychopharmacol 2018;28:682-9. [PMID: 30148656 DOI: 10.1089/cap.2018.0068] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shen E, Farukhi S, Schmutz M, Mosaed S. Acute Angle-closure Glaucoma Associated With Aripiprazole in the Setting of Plateau Iris Configuration. J Glaucoma 2018;27:e40-3. [PMID: 29189543 DOI: 10.1097/IJG.0000000000000836] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
8 Nikfarjam M, Rakhshan R, Ghaderi H. Comparison of Effect of Lavandula officinalis and Venlafaxine in Treating Depression: A Double Blind Clinical Trial. J Clin Diagn Res 2017;11:KC01-4. [PMID: 28892932 DOI: 10.7860/JCDR/2017/20657.10233] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Wang SM, Han C, Lee SJ, Jun TY, Patkar AA, Masand PS, Pae CU. Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update. Chonnam Med J 2016;52:159-72. [PMID: 27689026 DOI: 10.4068/cmj.2016.52.3.159] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]